Novo Nordisk · Living with obesity and cardiovascular disease: Juanpi's story · Life with diabetes · Life with obesity · Working at Novo Nordisk · About Novo ...

YouTube-Novo Nordisk

The popularity of Novo Nordisk's (NVO) blockbuster obesity drug Wegovy, and diabetes drug Ozempic, for weight loss, was so great in 2023 ...

YouTube-Yahoo Finance

The popularity of Novo Nordisk's (NVO) blockbuster obesity drug Wegovy, and diabetes drug Ozempic, for weight loss, was so great in 2023 ...

Yahoo Finance-Yahoo Finance

Jared Holz, Mizuho, joins 'Fast Money' to talk Novo Nordisk pulling back despite strong quarter.

YouTube-CNBC Television

Yahoo Finance selected pharmaceutical firm Novo Nordisk (NVO) as it's 2023 Company of the Year. Developer of obesity medications Wegovy and ...

YouTube-Yahoo Finance

Danish pharmaceutical company Novo Nordisk (NVO) topped first-quarter profit expectations, bringing in $9.5 billion in revenue over Wall ...

YouTube-Yahoo Finance

Ozempic and Wegovy, the diabetes and weight-loss drugs, have soared to celebrity status in the U.S. But Novo Nordisk, the Danish company ...

The New York Times-The New York Times

Novo Nordisk A/S is shipping more introductory doses of its blockbuster weight-loss drug Wegovy in the US as it grapples with supply ...

YouTube-Bloomberg Television

Join Ian King as Europe's biggest company Novo Nordisk raises its forecasts fuelled by high demand for its weight loss and diabetes drugs.

YouTube-Sky News

It's not often that a drug comes along that changes the course of history. Yet that's exactly what Novo Nordisk's Ozempic and its sister drug ...

Yahoo Finance-Corey Goldman

Learn more and see current vacant positions at www.novonordisk.com/careers. Play all · Shuffle · 1:49. Join Novo Nordisk for a life-changing ...

YouTube-Novo Nordisk

Novo Nordisk is built on a strong heritage from its founders. The story of how these scientists and innovators started insulin production in ...

YouTube-Novo Nordisk

"The Pulse With Francine Lacqua" is all about conversations with high profile guests in the beating heart of global business, economics, ...

Bloomberg.com-Bloomberg

CNBC's Silvia Amaro reports on the latest Novo Nordisk results.

CNBC

... Nordisk Foundation's Global Science Summit. Her address illuminates the critical connections among these fields and emphasizes the ...

YouTube-CGIAR

John Rountree, managing partner at Novasecta, comments on Danish pharma giant Novo Nordisk's first-quarter earnings.

CNBC

Novo Nordisk president and CEO Lars Fruergaard Jørgensen joins 'Money Movers' to discuss the company's latest trial results, ...

CNBC

Diabetes and obesity drugs Ozempic and Wegovy have become world famous, generating billions in sales and opening a new market for weight ...

YouTube-Bloomberg Television

'Mad Money' host Jim Cramer compares the weight loss drug offerings from Novo Nordisk and Eli Lilly and talks what investors need to know ...

YouTube-CNBC Television

John Rountree, managing partner at Novasecta, comments on Danish pharma giant Novo Nordisk's first-quarter earnings.

YouTube-CNBC International TV